Merck & Co., Inc. MRK
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 4.68% | 5.07% | 4.87% | 4.97% | 3.72% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.68% | 5.07% | 4.87% | 4.97% | 3.72% |
| Cost of Revenue | 17.84% | 21.70% | 14.54% | 15.86% | -3.68% |
| Gross Profit | 1.04% | 0.52% | 2.18% | 1.58% | 5.97% |
| SG&A Expenses | 11.49% | 11.26% | 6.74% | 1.56% | -2.44% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.55% | 68.44% | 7.42% | 46.47% | -16.81% |
| Operating Income | -9.63% | -100.68% | 1.06% | -33.62% | 61.53% |
| Income Before Tax | -17.58% | -113.66% | -159.87% | -17.99% | 64.91% |
| Income Tax Expenses | -48.64% | 14.54% | -13.33% | 7.51% | 3.12% |
| Earnings from Continuing Operations | -12.44% | -130.19% | -183.44% | -20.89% | 83.07% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 0.00% | 300.00% | 150.00% | 200.00% | 50.00% |
| Net Income | -12.45% | -130.16% | -183.48% | -20.84% | 83.24% |
| EBIT | -9.63% | -100.68% | 1.06% | -33.62% | 61.53% |
| EBITDA | -3.27% | -79.56% | 5.66% | -26.25% | 47.86% |
| EPS Basic | -11.49% | -130.65% | -185.20% | -19.28% | 86.10% |
| Normalized Basic EPS | -12.96% | -109.03% | -0.60% | -34.91% | 56.23% |
| EPS Diluted | -12.02% | -130.71% | -185.57% | -19.28% | 86.98% |
| Normalized Diluted EPS | -13.22% | -109.05% | -0.28% | -34.91% | 56.48% |
| Average Basic Shares Outstanding | -1.08% | -1.59% | -2.02% | -1.93% | -1.54% |
| Average Diluted Shares Outstanding | -0.80% | -1.71% | -2.33% | -1.93% | -1.69% |
| Dividend Per Share | 4.94% | 4.94% | 4.94% | 5.19% | 5.19% |
| Payout Ratio | 0.18% | -4.42% | -2.23% | 0.31% | -0.43% |